This specificity does not appear restricted to melanomas as the same TERT promoter mutations have emerged as a major driver in a multitude of human solid tumors (Heidenreich et al., 2014), including glioblastomas, medulloblastomas, carcinomas of the bladder, urothelial cancer (Borah et al., 2015), thyroid and squamous cell carcinomas of the tongue, as well as in liposarcomas and hepatocellular carcinomas (Heidenreich et al., 2014). This evidence concerns the gene TERT and melanoma.